Grant: Catalyst: Address.Musculoskeletal Cond./Arthritis in Cnd- Musculoskeletal trauma
University of Calgary
$100,000.00
Thrombelastography-Defined Duration of Hypercoagulability Following Pelvis and Acetabular Fractures
FY 2019-20
Summary
Patients who suffer a major broken bone, such as a broken pelvis or acetabulum (or hip socket), have an increased risk for developing blood clots in their legs (deep vein thrombosis or DVT) and life-threatening blood clots in their lungs (pulmonary embolism or PE). After these major broken bones, patients experience inflammation, which can be made worse by the surgery that they require, which further increases their risk for blood clots. PE is a common cause of preventable death in patients with a broken pelvis or acetabulum, therefore they receive medication to help prevent blood clots. However, these medications can increase bleeding and are expensive. It is unknown how long this medication should be continued and whether patients who are more prone to forming clots should receive longer treatment. In order to help prevent blood clots, doctors need to be able to identify which patients are at increased risk for clotting.
Thrombelastography (TEG) technology uses a small sample of blood to evaluate a person's risk for blood clots. Our study will test if TEG can also determine how long each patient should receive medication to minimize their clot risk, based on their individual risk. TEG technology is readily available, cost-effective, and provides valuable information to help doctors treat trauma patients with abnormal blood clotting.
Our interdisciplinary research team includes doctors and surgeons with TEG experience. This study will use blood tests and imaging studies to look for blood clots and abnormal inflammation in patients with a broken pelvis or acetabulum, both before and after surgery. We will determine the length of time that patients are in danger of developing life-threatening blood clots after their injury. Our results will help identify factors that increase clotting risk and will help develop protocols to minimize this risk. If our TEG study results help prevent blood clots, we will save the lives of trauma patients across Canada.
Department
Program
Catalyst: Address.Musculoskeletal Cond./Arthritis in Cnd- Musculoskeletal trauma
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
418364
Name
Schneider Prism S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians
Projecttitle
Thrombelastography-Defined Duration of Hypercoagulability Following Pelvis and Acetabular Fractures
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst: Address.Musculoskeletal Cond./Arthritis in Cnd- Musculoskeletal trauma
Keyworddelim
Acetabular Fracture; Deep Vein Thrombosis; Pelvic Fracture; Personalized Medicine; Point-Of-Care Test; Pulmonary Embolism; Thrombelastography; Trauma-Induced Coagulopathy; Venous Thromboembolism
Abstract
Patients who suffer a major broken bone, such as a broken pelvis or acetabulum (or hip socket), have an increased risk for developing blood clots in their legs (deep vein thrombosis or DVT) and life-threatening blood clots in their lungs (pulmonary embolism or PE). After these major broken bones, patients experience inflammation, which can be made worse by the surgery that they require, which further increases their risk for blood clots. PE is a common cause of preventable death in patients with a broken pelvis or acetabulum, therefore they receive medication to help prevent blood clots. However, these medications can increase bleeding and are expensive. It is unknown how long this medication should be continued and whether patients who are more prone to forming clots should receive longer treatment. In order to help prevent blood clots, doctors need to be able to identify which patients are at increased risk for clotting.
Thrombelastography (TEG) technology uses a small sample of blood to evaluate a person's risk for blood clots. Our study will test if TEG can also determine how long each patient should receive medication to minimize their clot risk, based on their individual risk. TEG technology is readily available, cost-effective, and provides valuable information to help doctors treat trauma patients with abnormal blood clotting.
Our interdisciplinary research team includes doctors and surgeons with TEG experience. This study will use blood tests and imaging studies to look for blood clots and abnormal inflammation in patients with a broken pelvis or acetabulum, both before and after surgery. We will determine the length of time that patients are in danger of developing life-threatening blood clots after their injury. Our results will help identify factors that increase clotting risk and will help develop protocols to minimize this risk. If our TEG study results help prevent blood clots, we will save the lives of trauma patients across Canada.
Competitiondate
201910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Schneider, Prism S; Bamasood, Saeed
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~